MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.14
-0.01 (-0.87%)
Performance
1D
—
1W
—
1M
—
3M
-5.79%
6M
-15.56%
1Y
-22.45%
YTD
-22.45%
Open$1.13
Previous Close$1.15
Day High$1.16
Day Low$1.13
52W High$3.95
52W Low$1.07
Volume—
Avg Volume128.9K
Market Cap43.44M
P/E Ratio—
EPS$-2.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.24
Below
RSI (14)
40.6
Neutral
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,584.2% upside
Current
$1.14
$1.14
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.57M | 22.51M | 24.43M |
| Net Income | -89,108,637 | -70,602,846 | -7,358,364 |
| Profit Margin | -348.5% | -331.1% | -30.1% |
| EBITDA | -91,975,920 | -76,923,253 | -8,749,975 |
| Free Cash Flow | — | — | -5,557,893 |
| Rev Growth | +13.6% | +13.6% | -4.6% |
| Debt/Equity | — | — | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |